Trial
NCT05845307
Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
M.D. Anderson Cancer Center
Collaborators
Tvardi Therapeutics, Inc; National Institutes of Health (NIH)
Condition
Squamous Cell Carcinoma of Head and Neck
Intervention
Control Group
Why stopped
0 participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-08